Philadelphia, PA
Mar 5- Mar 8, 2023

Conference Cochairs

Mariano Barbacid, Spanish National Cancer Center (CNIO), Madrid, Spain
Dafna Bar-Sagi, New York University Langone Medical Center, New York, New York
Frank McCormick, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Deborah K. Morrison, National Cancer Institute, Frederick, Maryland

Despite 40+ years of research on RAS genes – which drive growth in approximately one-third of all cancers – the cancer and biomedical research field is just starting to peel away the label of RAS as an “undruggable target.” The prognosis for many patients with RAS mutations (KRAS, NRAS, HRAS) continues to be poor, but incremental recent progress shows some promise in decreasing the clinical burden across several disease sites. Given the prominent role of RAS in so many human cancers, a comprehensive and in-depth forum for all constituents interested in RAS research is necessary to expand our knowledge of both the basic research pushing the field forward and the exciting potential for clinical application that translational science is advancing. This AACR Special Conference will cover a range of the topics including drug targeting, immunotherapy, metabolism, RASpathies, RAS structure and function, signaling networks, and several talks on RAS disease sites that provide opportunities for cross-cutting education.

Paris, France
Mar 6- Mar 8, 2023

ESMO TAT, known as “The Home of Phase I in Oncology”, is the leading congress focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development.
This congress will be dedicated to improving the conduct of early anti-cancer clinical trials, bringing together those who are developing the most promising new cancer drugs and unveiling exciting new data.

Florence, Italy
Mar 15- Mar 17, 2023


Paola Chiarugi, Università degli Studi di Firenze, Firenze, Italy (SIC)
Karlene A. Cimprich, Stanford University, Stanford, California, USA (AACR)
Vincenzo Costanzo, IFOM – Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy (EACR)
Alan D. D’Andrea, Dana-Farber Cancer Institute, Boston, Massachusetts, USA (AACR)
Caroline Dive, Cancer Research UK Manchester Institute, Manchester, England (EACR)
Gabriella Sozzi, Istituto Nazionale dei Tumori, Milano, Italy (SIC)

London, UK
Mar 28- Mar 29, 2023

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in cancer immunotherapy, with dedicated sessions on different therapeutic modalities as well as case studies on innovative preclinical and translational tools.

Orlando, FL
Apr 14- Apr 19, 2023

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

New York, NY
Apr 15- Apr 15, 2023

Meeting Chairs: Andreas Radbruch & Gerd R. Burmester
Theme: Protective and Pathogenic Plasma Cells
Annual Kunkel Memorial Lecturer: Jean-Claude Weill, INEM - Institut Necker-Enfants Malades, INSERM U1151/CNRS UMR8253, Université de Paris

Mainz, Germany
May 3- May 5, 2023

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Berlin, Germany and virtual
May 11- May 12, 2023

Cancer patients and their needs are at the heart of what we do – we are committed to advancing research and integrating it into the clinic to ensure better care for our patients. We aim to deliver a comprehensive overview of all the practice-changing new data and to make sure it has a clear roadmap to the clinic.

Boston, MA
Jun 26- Jun 29, 2023

Arthur, Sandra and Sarah Irving together with the Mass General Cancer Center are excited to announce the second annual “Arthur and Sandra Irving Cancer Immunology Symposium” to be held on June 26–29, 2023. The Symposium will bring together about 15 accomplished faculty mentors who are excited to share their discoveries and research career experience in cancer immunology with approximately 45 promising young scientists (post-docs and starting PIs).
Applicants are selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Deadline to apply: Tuesday, January 31, 2023

Milano, Italy
Sep 20- Sep 23, 2023


Mustafa Diken, Johannes Gutenberg University, Mainz, Germany
Marina Garassino, University of Chicago, Chicago, Illinois, USA
Nir Hacohen, Broad Institute of MIT and Harvard; Massachusetts General Hospital, Boston, Massachusetts, USA
Susan M. Kaech, The Salk Institute for Biological Studies, La Jolla, California, USA
Paola Nisticò, Regina Elena National Cancer Institute, Rome, Italy
Pamela S. Ohashi, University of Toronto, Toronto, ON, Canada
Catherine Sautès-Fridman, University Paris-Descartes, Paris, France
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Özlem Türeci, BioNTech SE, Mainz, Germany
Cassian Yee, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Laurence Zitvogel, Gustave Roussy Institute, Villejuif, France

Paris, France
Sep 28- Sep 30, 2023

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalized medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology await you for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance. The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

Toronto, Canada
Oct 1- Oct 4, 2023


Philip D. Greenberg, Fred Hutchinson Cancer Research Center, Seattle, Washington
Pamela S. Ohashi, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York
Mario Sznol, Yale University, New Haven, Connecticut

Madrid, Spain
Oct 20- Oct 24, 2023

ESMO 2023 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

San Diego, CA
Nov 1- Nov 5, 2023


Barcelona, Spain
Sep 13- Sep 17, 2024

ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.